Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000021

Chief Medical Officer acquired 6,349 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2025-03-12 Option exercise +6,349 $1.08 $6,857 170,869 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2025-03-12 Option exercise · Stock Option −6,349 115,880 D: show line 2 in the form
Loading xslF345X05/wk-form4_1741900533.xml…